Skip to content

MEDIDENT: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDIDENT

BE 0674.755.457
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€9,467
2024 · €3,746-€13,213
Equity
€2,628
2024 · €12,095-€9,467
Cash
€2,343
2024 · €3,092-€749
Balance sheet total
€185,879
2024 · €200,715-€14,837

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€13,560

    down €13,560 (-63.5%), from €21,352 to €7,792

  • Stocks and contracts -€3,680

    down €3,680 (-2.2%), from €163,883 to €160,204

  • Tangible fixed assets +€3,152

    up €3,152 (+25.4%), from €12,387 to €15,540

    of which Plant, machinery and equipment: +€3,152

Equity and liabilities
  • Profit (loss) carried forward -€9,467

    down €9,467, from €5,416 to -€4,051

  • Debts after one year +€8,250

    up €8,250 (+5.1%), from €162,399 to €170,649

    of which Other amounts payable: +€8,250

  • Tax, wage and social debts -€6,066

    down €6,066 (-56.3%), from €10,775 to €4,709

  • Trade debts -€5,141

    down €5,141 (-43.5%), from €11,815 to €6,674

  • Accrued charges and deferred income -€2,413

    down €2,413 (-66.4%), from €3,631 to €1,218

Income statement
  • Gross operating margin -€31,851

    down €31,851, from €18,704 to -€13,147

  • Financial income +€11,414

    up €11,414 (+28534375.0%), from €0 to €11,414

  • Depreciation -€3,614

    down €3,614 (-100.0%), from €3,614 to €0

  • Financial charges -€3,562

    down €3,562 (-35.6%), from €10,009 to €6,447

  • Other operating charges -€460

    down €460 (-26.3%), from €1,747 to €1,286

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €3,746
Gross operating margin -€31,851
Depreciation +€3,614
Other operating charges +€460
Financial income +€11,414
Financial charges +€3,562
Taxes -€411
Result 2025 -€9,467

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€5,847
Investment -€3,152
Financing +€8,250
Cash 2024 €3,092
Net result for the year -€9,467
Stocks and contracts +€3,680
Receivables within one year +€13,560
Trade debts -€5,141
Tax, wage and social debts -€6,066
Accrued charges and deferred income -€2,413
Investment in fixed assets (net) -€3,152
Debts after one year +€8,250
Cash 2025 €2,343
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €200,715 €185,879 -€14,837 -7.4%
Fixed assets 21/28 €12,387 €15,540 +€3,152 +25.4%
Tangible fixed assets 22/27 €12,387 €15,540 +€3,152 +25.4%
Land and buildings 22 €0 €0 = 0.0%
Plant, machinery and equipment 23 €11,892 €15,044 +€3,152 +26.5%
Furniture and vehicles 24 €496 €496 = 0.0%
Current assets 29/58 €188,328 €170,339 -€17,989 -9.6%
Stocks and contracts in progress 3 €163,883 €160,204 -€3,680 -2.2%
Stocks 30/36 €163,883 €160,204 -€3,680 -2.2%
Amounts receivable within one year 40/41 €21,352 €7,792 -€13,560 -63.5%
Trade receivables 40 €21,352 €7,792 -€13,560 -63.5%
Cash at bank and in hand 54/58 €3,092 €2,343 -€749 -24.2%
Total equity and liabilities 10/49 €200,715 €185,879 -€14,837 -7.4%
Equity 10/15 €12,095 €2,628 -€9,467 -78.3%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €479 €479 = 0.0%
Non-distributable reserves 130/1 €479 €479 = 0.0%
Reserves not available under the articles 1311 €479 €479 = 0.0%
Profit (loss) carried forward 14 €5,416 -€4,051 -€9,467
Amounts payable 17/49 €188,620 €183,250 -€5,370 -2.8%
Amounts payable after more than one year 17 €162,399 €170,649 +€8,250 +5.1%
Financial debts 170/4 €35,000 €35,000 = 0.0%
Other amounts payable 178/9 €127,399 €135,649 +€8,250 +6.5%
Amounts payable within one year 42/48 €22,591 €11,383 -€11,207 -49.6%
Trade debts 44 €11,815 €6,674 -€5,141 -43.5%
Suppliers 440/4 €11,815 €6,674 -€5,141 -43.5%
Taxes, remuneration and social security 45 €10,775 €4,709 -€6,066 -56.3%
Taxes 450/3 €10,775 €4,709 -€6,066 -56.3%
Accrued charges and deferred income 492/3 €3,631 €1,218 -€2,413 -66.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,614 €0 -€3,614 -100.0%
Other operating charges 640/8 €1,747 €1,286 -€460 -26.3%
Gross operating margin 9900 €18,704 -€13,147 -€31,851
Operating profit (loss) 9901 €13,344 -€14,434 -€27,777
Financial income 75/76B €0 €11,414 +€11,414 +28534375.0%
Recurring financial income 75 €0 €11,414 +€11,414 +28534375.0%
Financial charges 65/66B €10,009 €6,447 -€3,562 -35.6%
Recurring financial charges 65 €10,009 €6,447 -€3,562 -35.6%
Profit (loss) for the period before taxes 9903 €3,335 -€9,467 -€12,802
Income taxes 67/77 -€411 €0 +€411
Profit (loss) for the period 9904 €3,746 -€9,467 -€13,213
Profit (loss) for the period to be appropriated 9905 €3,746 -€9,467 -€13,213

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.